These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9771014)

  • 1. [The influence of 3-month treatment with molsidomine on structure, function and some neurohormonal parameters in patients with chronic heart failure treated with digoxin, diuretic and angiotensin converting enzyme inhibitors].
    Spring A; Jołda-Mydłowska B; Kosmala W; Witkowska M
    Pol Merkur Lekarski; 1998 Jun; 4(24):315-8. PubMed ID: 9771014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasodilator hormonal agents in chronic heart failure: effect of angiotensin-converting enzyme inhibitors].
    Godoy I; Corbalán R; Jalil J; Guarda E; Albertini R
    Rev Med Chil; 1997 Feb; 125(2):135-42. PubMed ID: 9430932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.
    Badenhorst D; Norton GR; Sliwa K; Brooksbank R; Essop R; Sareli P; Woodiwiss AJ
    Pharmacogenomics J; 2007 Oct; 7(5):339-45. PubMed ID: 17117186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adaptation of guidelines for the treatment of chronic heart failure in a specialized heart failure clinic].
    Pölzl G; Gouya G; Hügel H; Frick M; Ulmer H; Pachinger O
    Wien Klin Wochenschr; 2002 Oct; 114(19-20):833-9. PubMed ID: 12503474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of long-term treatment with pimobendan on neurohumoral factors in patients with non-ischemic chronic moderate heart failure.
    Sasaki T; Kubo T; Komamura K; Nishikimi T
    J Cardiol; 1999 Jun; 33(6):317-25. PubMed ID: 10396705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
    van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
    Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of the acute administration of molsidomine in refractory congestive heart failure. A double-blind randomized non-invasive study].
    Coletta C; Galati A; Carunchio A; Salustri A; Bordi L; Fera MS
    G Ital Cardiol; 1986 Mar; 16(3):232-6. PubMed ID: 3755412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should all patients with congestive heart failure and dilated cardiomyopathy be treated with vasodilators?
    Massie BM
    Cardiovasc Clin; 1990; 21(1):251-62; discussion 263-4. PubMed ID: 2199051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term oral administration of dipyridamole improves both cardiac and physical status in patients with mild to moderate chronic heart failure: a prospective open-randomized study.
    Sanada S; Asanuma H; Koretsune Y; Watanabe K; Nanto S; Awata N; Hoki N; Fukunami M; Kitakaze M; Hori M
    Hypertens Res; 2007 Oct; 30(10):913-9. PubMed ID: 18049022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of angiotensin converting enzyme inhibitor with different doses on plasma brain natriuretic peptide and norepinephrine in patients with chronic heart failure].
    Song HM; Zhang J; Deng B; Luo M
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1737-40. PubMed ID: 16253158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, randomized, placebo-controlled study of high-dose HMG CoA reductase inhibitor therapy on ventricular remodeling, pro-inflammatory cytokines and neurohormonal parameters in patients with chronic systolic heart failure.
    Krum H; Ashton E; Reid C; Kalff V; Rogers J; Amarena J; Singh B; Tonkin A
    J Card Fail; 2007 Feb; 13(1):1-7. PubMed ID: 17338996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of medical treatment on lung diffusion capacity in elderly patients with heart failure. Baseline characteristics and 1-year follow up after medical treatment.
    Petersen CL; Kjaer A
    Int J Cardiol; 2005 Feb; 98(3):453-7. PubMed ID: 15708179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congestive heart failure and ventricular arrhythmias in relation to serum magnesium.
    Oladapo OO; Falase AO
    Afr J Med Med Sci; 2000; 29(3-4):265-8. PubMed ID: 11714003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Level of angiotensin II and aldosterone in plasma is often elevated in patients with heart failure treated with converting enzyme inhibitors--preliminary results].
    Grzybowski J; Bilińska ZT; Janas J; Michalak E; Skwarek M; Ruzyłło W
    Przegl Lek; 2002; 59(8):587-9. PubMed ID: 12638326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of increasing maintenance dose of digoxin on left ventricular function and neurohormones in patients with chronic heart failure treated with diuretics and angiotensin-converting enzyme inhibitors.
    Gheorghiade M; Hall VB; Jacobsen G; Alam M; Rosman H; Goldstein S
    Circulation; 1995 Oct; 92(7):1801-7. PubMed ID: 7671364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trends in pharmacological treatment of congestive heart failure].
    Halawa B
    Pol Merkur Lekarski; 1999 Mar; 6(33):152-6. PubMed ID: 10365602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.